Popular Trials
Behavioural Intervention
NAC + Night Splints for Carpal Tunnel Syndrome
This trial is testing whether taking a supplement called N-acetylcysteine (NAC) along with wearing a wrist splint at night can help people with mild to moderate carpal tunnel syndrome. The goal is to see if this combination reduces symptoms like pain and numbness better than just using a wrist splint alone. NAC is known for its anti-inflammatory effects, which might help improve nerve function and reduce the need for surgery.
Behavioural Intervention
Educational Videos for Carpal Tunnel Syndrome
This trial aims to see if using short educational videos for postoperative care after carpal tunnel release surgery can make patients happier and reduce the need for healthcare resources. Patients will watch three short videos about post
Popular Filters
Trials for CTS Patients
Behavioural Intervention
CASA Device for Carpal Tunnel Syndrome
This trial will test a new device for treating carpal tunnel syndrome that applies a gentle force to the wrist while being worn during sleep. The effectiveness of the device will be measured by comparing patient-reported outcomes
Flavonoid
Fisetin for Carpal Tunnel Syndrome
This trial is testing Fisetin, a supplement, to see if it can help people with mild to moderate carpal tunnel syndrome. The study will involve 40 participants who show signs of aging cells in their blood. Fisetin aims to reduce these aging cells and inflammation, potentially improving CTS symptoms.
Diagnostic Device
Ultrasound with Shearwave Elastography for Carpal Tunnel Syndrome
This trial is testing a new ultrasound method to check for stiffness and other issues in the wrists of patients, especially after treatments like surgery or injections. The ultrasound uses sound waves to take detailed pictures of the inside of the wrist.
Trials With No Placebo
Behavioural Intervention
CASA Device for Carpal Tunnel Syndrome
This trial will test a new device for treating carpal tunnel syndrome that applies a gentle force to the wrist while being worn during sleep. The effectiveness of the device will be measured by comparing patient-reported outcomes
Flavonoid
Fisetin for Carpal Tunnel Syndrome
This trial is testing Fisetin, a supplement, to see if it can help people with mild to moderate carpal tunnel syndrome. The study will involve 40 participants who show signs of aging cells in their blood. Fisetin aims to reduce these aging cells and inflammation, potentially improving CTS symptoms.
Diagnostic Device
Ultrasound with Shearwave Elastography for Carpal Tunnel Syndrome
This trial is testing a new ultrasound method to check for stiffness and other issues in the wrists of patients, especially after treatments like surgery or injections. The ultrasound uses sound waves to take detailed pictures of the inside of the wrist.
View More Related Trials
Frequently Asked Questions
Introduction to carpal tunnel
What are the top hospitals conducting carpal tunnel research?
Carpal tunnel syndrome is a common condition that affects millions of individuals worldwide, causing pain and discomfort in the hands and wrists. Thankfully, several top hospitals are dedicated to finding innovative treatments through clinical trials. One such institution is the Mayo Clinic in Rochester, known for its cutting-edge research. Currently, they have three active carpal tunnel trials and have conducted five studies overall since their first recorded trial in 2014. In Boston, Massachusetts General Hospital stands out with two ongoing carpal tunnel trials and a total of five completed studies since their initial trial in 2009.
Moving to Chicago, the University of Chicago Medicine joins this list with one active carpal tunnel trial and one completed study thus far—both being remarkable achievements considering their relatively recent entry into this field, beginning only in 2023. Similarly contributing to the advancement of knowledge on carpal tunnel syndrome is Bluegrass Orthopaedics based in Lexington; despite having just initiated their first recorded trial also during 2023, they are already making strides with one ongoing clinical investigation.
Finally making its mark within this domain is none other than the University of Nevada located amidst Las Vegas's vibrant atmosphere where emerging medical professionals contribute towards combating this ailment as well.They currently run an active carpal tunnel trial alongside their inaugural case dating back barely few years ago-also commencing during late2023.Even though considered rather new entrants into these respective areas both remain poised to play vital roles toward addressing this widespread issue.
These hospitals represent beacons of hope for those suffering from carpal tunnel syndrome by striving tirelessly to find better treatment options through rigorous scientific inquiry. Their commitment showcases not only dedication but also our collective pursuit for improved quality of life—one step at a time
Which are the best cities for carpal tunnel clinical trials?
When it comes to carpal tunnel clinical trials, several cities have emerged as leaders in researching and developing new treatments. Rochester, Minnesota stands out with its three active trials focusing on interventions like Fisetin, FDA approved ultrasound systems with shear wave elastography capability, and wound closure techniques. Boston, Massachusetts follows closely behind with two ongoing studies investigating CTR-US and acupuncture - distal methods. Additionally, Chicago, Illinois; Lexington, Kentucky; and Las Vegas, Nevada each have one active trial centered around innovative approaches such as experimental ice therapy or CTR-US. These cities provide individuals suffering from carpal tunnel syndrome access to cutting-edge clinical research that may lead to improved treatment options and enhanced quality of life.
Which are the top treatments for carpal tunnel being explored in clinical trials?
In the realm of carpal tunnel treatment, clinical trials are currently exploring several promising options. Among them are:
- CTR-US: This innovative treatment is being tested in two active trials and has shown potential in one all-time carpal tunnel trial since its introduction in 2022.
- Fisetin: Another contender on the horizon, fisetin is making waves with its involvement in one ongoing trial and one all-time carpal tunnel trial since 2022.
- FDA approved ultrasound system with shear wave elastography capability: This cutting-edge technology has caught the attention of researchers, participating in one active and one all-time carpal tunnel trial ever since it was first listed back in 2021.
- Transcranial Direct Current Stimulation (tdcs): Emerging as a potentially effective option for carpal tunnel, tDCS is currently involved in one active trial along with an all-time carpal tunnel trial initiated in 2021.
These treatments offer hope to individuals suffering from this debilitating condition by paving the way for future advancements and improved quality of life.
What are the most recent clinical trials for carpal tunnel?
New research and clinical trials offer hope for those suffering from carpal tunnel syndrome, a common condition that causes pain and numbness in the hand and wrist. One recent study investigated the potential benefits of fisetin, a natural compound known for its anti-inflammatory properties. Another trial explored the use of N-acetyl cysteine to alleviate symptoms associated with carpal tunnel. Additionally, researchers examined the effectiveness of wrist splints in managing this condition. Conditioning electrical stimulation was also investigated as a potential treatment option. Finally, a study focused on comparing different pain management strategies for carpal tunnel syndrome. These exciting developments showcase ongoing efforts to improve care and enhance quality of life for individuals affected by this debilitating condition.
What carpal tunnel clinical trials were recently completed?
Recently, several clinical trials investigating treatments for carpal tunnel syndrome have concluded. These studies aimed to uncover new and effective therapies for this common condition that causes pain and numbness in the hand and wrist. Researchers conducted a trial testing the efficacy of a drug called Neurogel, which was completed in October 2021. The National Institute of Neurological Disorders and Stroke (NINDS) also sponsored a trial examining the effectiveness of physical therapy interventions, which concluded in September 2021. Another study focused on evaluating the benefits of acupuncture as a potential treatment option for carpal tunnel syndrome, wrapping up in January 2021. These recent advancements provide valuable insights into improving care for individuals suffering from this debilitating condition.